Screening Accuracy of FeNO Measurement for Childhood Asthma in a Community Setting
(1) Background: The exhaled fractional nitric oxide is a well-recognized biomarker used in clinical settings for controlling and managing asthma. Less is known about the value of Fractional Exhaled Nitric Oxide (FeNO) measurement in epidemiological studies on childhood asthma, although available evi...
Saved in:
Main Authors: | Kamil Barański (Author), Jan Eugeniusz Zejda (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of FeNO in Predicting Asthma
by: Mariëlle W. Pijnenburg
Published: (2019) -
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
by: Brooks EA, et al.
Published: (2019) -
Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden
by: Darbà J, et al.
Published: (2021) -
FENO AND ATOPY IN PEDIATRIC ASTHMA
by: Cristiana Stanciulescu, et al.
Published: (2015) -
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
by: Beatrice Ragnoli, et al.
Published: (2023)